Literature DB >> 33522086

Increased APOE ε4 expression is associated with the difference in Alzheimer's disease risk from diverse ancestral backgrounds.

Anthony J Griswold1,2, Katrina Celis1, Parker L Bussies1, Farid Rajabli1, Patrice L Whitehead1, Kara L Hamilton-Nelson1, Gary W Beecham1,2, Derek M Dykxhoorn1,2, Karen Nuytemans1,2, Liyong Wang1,2, Olivia K Gardner1, Daniel A Dorfsman1, Eileen H Bigio3, Marek Marsel Mesulam3, Sandra Weintraub3, Changiz Geula3, Marla Gearing4, Elisa McGrath-Martinez5,6, Clifton L Dalgard6,7, William K Scott1,2, Jonathan L Haines8, Margaret A Pericak-Vance1,2, Juan I Young1,2, Jeffery M Vance1,2.   

Abstract

INTRODUCTION: Apolipoprotein E (APOE) ε4 confers less risk for Alzheimer's disease (AD) in carriers with African local genomic ancestry (ALA) than APOE ε4 carriers with European local ancestry (ELA). Cell type specific transcriptional variation between the two local ancestries (LAs) could contribute to this disease risk differences.
METHODS: Single-nucleus RNA sequencing was performed on frozen frontal cortex of homozygous APOE ε4/ε4 AD patients: seven with ELA, four with ALA.
RESULTS: A total of 60,908 nuclei were sequenced. Within the LA region (chr19:44-46Mb), APOE was the gene most differentially expressed, with ELA carriers having significantly more expression (overall P < 1.8E-317 ) in 24 of 32 cell clusters. The transcriptome of one astrocyte cluster, with high APOE ε4 expression and specific to ELA, is suggestive of A1 reactive astrocytes. DISCUSSION: AD patients with ELA expressed significantly greater levels of APOE than ALA APOE ε4 carriers. These differences in APOE expression could contribute to the reduced risk for AD seen in African APOE ε4 carriers.
© 2021 the Alzheimer's Association.

Entities:  

Keywords:  APOE; Alzheimer's disease; local ancestry; single-nucleus RNA-seq

Mesh:

Substances:

Year:  2021        PMID: 33522086      PMCID: PMC8843031          DOI: 10.1002/alz.12287

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


  43 in total

1.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

2.  RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference.

Authors:  Brian K Maples; Simon Gravel; Eimear E Kenny; Carlos D Bustamante
Journal:  Am J Hum Genet       Date:  2013-08-01       Impact factor: 11.025

3.  Mutation analysis of chromosome 19 calmodulin (CALM3) gene in Alzheimer's disease patients.

Authors:  D Ibarreta; J Tao; R Parrilla; M S Ayuso
Journal:  Neurosci Lett       Date:  1997-07-04       Impact factor: 3.046

4.  Neurotoxic reactive astrocytes are induced by activated microglia.

Authors:  Shane A Liddelow; Kevin A Guttenplan; Laura E Clarke; Frederick C Bennett; Christopher J Bohlen; Lucas Schirmer; Mariko L Bennett; Alexandra E Münch; Won-Suk Chung; Todd C Peterson; Daniel K Wilton; Arnaud Frouin; Brooke A Napier; Nikhil Panicker; Manoj Kumar; Marion S Buckwalter; David H Rowitch; Valina L Dawson; Ted M Dawson; Beth Stevens; Ben A Barres
Journal:  Nature       Date:  2017-01-18       Impact factor: 49.962

5.  Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics.

Authors:  Elizabeth E Blue; Andréa R V R Horimoto; Shubhabrata Mukherjee; Ellen M Wijsman; Timothy A Thornton
Journal:  Alzheimers Dement       Date:  2019-10-09       Impact factor: 21.566

Review 6.  Biomarker modeling of Alzheimer's disease.

Authors:  Clifford R Jack; David M Holtzman
Journal:  Neuron       Date:  2013-12-18       Impact factor: 17.173

7.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

8.  ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.

Authors:  Yang Shi; Kaoru Yamada; Shane Antony Liddelow; Scott T Smith; Lingzhi Zhao; Wenjie Luo; Richard M Tsai; Salvatore Spina; Lea T Grinberg; Julio C Rojas; Gilbert Gallardo; Kairuo Wang; Joseph Roh; Grace Robinson; Mary Beth Finn; Hong Jiang; Patrick M Sullivan; Caroline Baufeld; Michael W Wood; Courtney Sutphen; Lena McCue; Chengjie Xiong; Jorge L Del-Aguila; John C Morris; Carlos Cruchaga; Anne M Fagan; Bruce L Miller; Adam L Boxer; William W Seeley; Oleg Butovsky; Ben A Barres; Steven M Paul; David M Holtzman
Journal:  Nature       Date:  2017-09-20       Impact factor: 69.504

9.  Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis.

Authors:  Brian W Kunkle; Michael Schmidt; Hans-Ulrich Klein; Adam C Naj; Kara L Hamilton-Nelson; Eric B Larson; Denis A Evans; Phil L De Jager; Paul K Crane; Joe D Buxbaum; Nilufer Ertekin-Taner; Lisa L Barnes; M Daniele Fallin; Jennifer J Manly; Rodney C P Go; Thomas O Obisesan; M Ilyas Kamboh; David A Bennett; Kathleen S Hall; Alison M Goate; Tatiana M Foroud; Eden R Martin; Li-Sao Wang; Goldie S Byrd; Lindsay A Farrer; Jonathan L Haines; Gerard D Schellenberg; Richard Mayeux; Margaret A Pericak-Vance; Christiane Reitz; Neill R Graff-Radford; Izri Martinez; Temitope Ayodele; Mark W Logue; Laura B Cantwell; Melissa Jean-Francois; Amanda B Kuzma; L D Adams; Jeffery M Vance; Michael L Cuccaro; Jaeyoon Chung; Jesse Mez; Kathryn L Lunetta; Gyungah R Jun; Oscar L Lopez; Hugh C Hendrie; Eric M Reiman; Neil W Kowall; James B Leverenz; Scott A Small; Allan I Levey; Todd E Golde; Andrew J Saykin; Takiyah D Starks; Marilyn S Albert; Bradley T Hyman; Ronald C Petersen; Mary Sano; Thomas Wisniewski; Robert Vassar; Jeffrey A Kaye; Victor W Henderson; Charles DeCarli; Frank M LaFerla; James B Brewer; Bruce L Miller; Russell H Swerdlow; Linda J Van Eldik; Henry L Paulson; John Q Trojanowski; Helena C Chui; Roger N Rosenberg; Suzanne Craft; Thomas J Grabowski; Sanjay Asthana; John C Morris; Stephen M Strittmatter; Walter A Kukull
Journal:  JAMA Neurol       Date:  2021-01-01       Impact factor: 29.907

10.  Use of local genetic ancestry to assess TOMM40-523' and risk for Alzheimer disease.

Authors:  Parker L Bussies; Farid Rajabli; Anthony Griswold; Daniel A Dorfsman; Patrice Whitehead; Larry D Adams; Pedro R Mena; Michael Cuccaro; Jonathan L Haines; Goldie S Byrd; Gary W Beecham; Margaret A Pericak-Vance; Juan I Young; Jeffery M Vance
Journal:  Neurol Genet       Date:  2020-03-03
View more
  7 in total

1.  Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer's disease.

Authors:  Alice Taubes; Phil Nova; Kelly A Zalocusky; Idit Kosti; Mesude Bicak; Misha Y Zilberter; Yanxia Hao; Seo Yeon Yoon; Tomiko Oskotsky; Silvia Pineda; Bin Chen; Emily A Aery Jones; Krishna Choudhary; Brian Grone; Maureen E Balestra; Fayzan Chaudhry; Ishan Paranjpe; Jessica De Freitas; Nicole Koutsodendris; Nuo Chen; Celine Wang; William Chang; Alice An; Benjamin S Glicksberg; Marina Sirota; Yadong Huang
Journal:  Nat Aging       Date:  2021-10-11

2.  Global and local ancestry modulate APOE association with Alzheimer's neuropathology and cognitive outcomes in an admixed sample.

Authors:  Michel Satya Naslavsky; Claudia K Suemoto; Luciano Abreu Brito; Marília Oliveira Scliar; Renata Eloah Ferretti-Rebustini; Roberta Diehl Rodriguez; Renata E P Leite; Nathalia Matta Araujo; Victor Borda; Eduardo Tarazona-Santos; Wilson Jacob-Filho; Carlos Pasqualucci; Ricardo Nitrini; Kristine Yaffe; Mayana Zatz; Lea T Grinberg
Journal:  Mol Psychiatry       Date:  2022-09-07       Impact factor: 13.437

3.  A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer's Disease in African Ancestry.

Authors:  Farid Rajabli; Gary W Beecham; Hugh C Hendrie; Olusegun Baiyewu; Adesola Ogunniyi; Sujuan Gao; Nicholas A Kushch; Marina Lipkin-Vasquez; Kara L Hamilton-Nelson; Juan I Young; Derek M Dykxhoorn; Karen Nuytemans; Brian W Kunkle; Liyong Wang; Fulai Jin; Xiaoxiao Liu; Briseida E Feliciano-Astacio; Gerard D Schellenberg; Clifton L Dalgard; Anthony J Griswold; Goldie S Byrd; Christiane Reitz; Michael L Cuccaro; Jonathan L Haines; Margaret A Pericak-Vance; Jeffery M Vance
Journal:  PLoS Genet       Date:  2022-07-05       Impact factor: 6.020

Review 4.  Astrocytes in Neurodegeneration: Inspiration From Genetics.

Authors:  Jingxuan Huang; Chunyu Li; Huifang Shang
Journal:  Front Neurosci       Date:  2022-06-24       Impact factor: 5.152

5.  Genetic architecture of RNA editing regulation in Alzheimer's disease across diverse ancestral populations.

Authors:  Olivia K Gardner; Derek Van Booven; Lily Wang; Tianjie Gu; Natalia K Hofmann; Patrice L Whitehead; Karen Nuytemans; Kara L Hamilton-Nelson; Larry D Adams; Takiyah D Starks; Michael L Cuccaro; Eden R Martin; Jeffery M Vance; William S Bush; Goldie S Byrd; Jonathan L Haines; Gary W Beecham; Margaret A Pericak-Vance; Anthony J Griswold
Journal:  Hum Mol Genet       Date:  2022-08-25       Impact factor: 5.121

6.  A Method for Bridging Population-Specific Genotypes to Detect Gene Modules Associated with Alzheimer's Disease.

Authors:  Yulin Dai; Peilin Jia; Zhongming Zhao; Assaf Gottlieb
Journal:  Cells       Date:  2022-07-16       Impact factor: 7.666

Review 7.  Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological Effects.

Authors:  Femke M Feringa; Rik van der Kant
Journal:  Front Aging Neurosci       Date:  2021-06-24       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.